Back to search
FDAFDA · Food and drugs·Recall number Z-0438-2023

Arrow AC3 Optimus Intra-Aortic Balloon Pump, AC3 Optimus IABP NA/EMEA, REF IAP-0700 (IPN001112), cardiac pump

Published December 21, 2022 · Recall initiated: October 17, 2022

Summary

FDA records medical device Class I recall Z-0438-2023, published December 21, 2022 and initiated October 17, 2022. Recalling firm: ARROW INTERNATIONAL Inc.; Status: Ongoing; Reported quantity: N/A; Lot: UDI/DI (01) 0 0801902 08496 5, (01) 0 0801902 08496 6, All Lot/Serial Numbers. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential issue with short battery run-times on the affected intra-aortic balloon pump (IABP) devices.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
ARROW INTERNATIONAL Inc.
Distributor
Worldwide
Lot
UDI/DI (01) 0 0801902 08496 5, (01) 0 0801902 08496 6, All Lot/Serial Numbers
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Arrow AC3 Optimus Intra-Aortic Balloon Pump, AC3 Optimus IABP NA/EMEA, REF IAP-0700 (IPN001112), cardiac pump recalled?

Yes. FDA published recall Z-0438-2023 on December 21, 2022. Reported hazard: There is a potential issue with short battery run-times on the affected intra-aortic balloon pump (IABP) devices.

What should I do if I have this product?

Voluntary: Firm initiated · Letter